Data shows significant prevalence of sleep apnea among cardio-oncology patients
According to researchers, sleep apnea could be used as a risk factor for patients at higher risk for developing congestive heart failure following cancer treatment
2024-02-09
(Press-News.org) Sleep apnea is prevalent among cardio-oncology patients who are at higher risk for congestive heart failure from cancer therapy, according to a new study being presented at the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient course.
Sleep apnea is a disorder of altered breathing while asleep with two types, obstructive (OSA) or central (CSA). Both can be treated to alleviate symptoms and improve cardiovascular outcomes. This study pertains to obstructive sleep apnea. A well-established screening tool for detecting sleep apnea is the STOP-BANG questionnaire utilizing eight questions using the acronym STOP-BANG (Snoring, Tiredness, Observed apnea, Pressure -elevated blood pressure, BMI, Age, Neck, Gender). It is scored based on yes/no answers with a range from 0-8. A score > 3 shows a high sensitivity for detecting moderate and severe OSA.
Among heart failure patients in the general population, OSA maintains a 48-52% prevalence and is associated with heightened cardiovascular mortality and morbidity rates. Previous studies have found that left ventricular ejection fraction (a measure used to determine how well the heart is pumping blood throughout the body) and Global Longitudinal LV Strain (GLS—a measure of how much the cell shrinks in size to generate the force to eject the blood out of the heart) can predict early cancer therapy related cardiomyopathy. OSA is also linked to LV dysfunction, congestive heart failure and abnormal LV-GLS.
While cardio-oncology patients have a higher risk for congestive heart failure from cancer therapy, there is no data on the prevalence of sleep apnea within this group. The researchers used a sleep apnea questionnaire to assess the prevalence of sleep apnea among 296 general cardiology patients and 218 cardio-oncology patients. Data was collected on traditional risk factors, STOP-BANG scores, and history of sleep for both groups. Baseline echocardiogram left ventricular ejection fraction (LVEF)and GLS results were measured for the cardio-oncology population.
“Echocardiogram has evolved to be a useful tool to detect and therefore treat cardiomyopathy early in patients with sleep apnea and in the cardio-oncology population, so we also wanted to see if there are shared echo markers that identify patients who are at greater risk as they start their journey to treat their cancer,” said Mini K. Das, MD, medical director of the cardio-oncology program at Baptist Health in Louisville, Kentucky and the study’s primary author.
The incidence of sleep apnea was 54% in the general cardiology group and 39% in the cardio-oncology group. The prevalence of sleep apnea within the general cardiology group was similar to reported rates in patients with heart failure with reduced ejection fraction (HFrEF) or heart failure with preserved ejection fraction (HFpEF), where the rates were 52% with HFrEF and 48% with HFpEF. HFrEF and HFpEF are the two most common types of heart failure and indicate the heart is either too weak to pump properly (HFrEF) or too stiff to fill properly with blood (HFpEF). According to the results of a questionnaire for sleep apnea using the STOP-BANG score, individuals with untreated sleep apnea and those who are at higher risk for sleep apnea have abnormal baseline left ventricular strain, which is a common echo parameter linked to adverse CV events.
“Identifying these individuals may allow early intervention in a risk factor clearly associated with heart failure now recognized to affect cancer therapy and survivorship,” Das said.
The prevalence of sleep apnea in the cardio-oncology population was equal to or greater than other traditional risk factors that are currently used in risk factor profile algorithms. Even with a normal LVEF, the status and severity of sleep apnea was associated with abnormal LV strain. The results of this study show that LV GLS was more abnormal in patients with untreated sleep apnea or a high STOP-BANG score.
“Sleep apnea should be incorporated into current risk algorithms and a larger study is needed to evaluate the impact of sleep apnea in this high-risk population. We feel that sleep apnea assessment must be a part of routine risk assessment for patients undergoing cancer therapeutics,” Das said.
ACC Advancing the Cardiovascular Care of the Oncology Patient course is an interdisciplinary course that highlights emerging strategies and best practices for managing the heart health of cancer patients.
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-02-09
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat. The emergence of the BA.2.86 variant, a subvariant of Omicron, has raised significant concerns due to its substantial number of mutations. Discovered in August 2023, this variant differs markedly from other existing types such as Omicron XBB (including EG.5.1 and HK.3). Compared with XBB and BA.2, BA.2.86 exhibits more than 30 mutations in its spike protein, contributing to its ability to effectively evade the immune system’s defenses.
Over ...
2024-02-09
Sensory feedback is important for amputees to be able to explore and interact with their environment. Now, researchers have developed a device that allows amputees to sense and respond to temperature by delivering thermal information from the prosthesis’ fingertip to the amputee’s residual limb. The “MiniTouch” device, presented February 9 in the journal Med, uses off-the-shelf electronics, can be integrated into commercially available prosthetic limbs, and does not require surgery. Using the thermally sensitive prosthetic hand, ...
2024-02-09
Pisa, 9 February 2024. “When one of the researchers placed the sensor on his own body, I could feel the warmth of another person with my phantom hand. it was a very strong emotion for me, it was like reactivating a connection with someone”.
Thanks to a sensorised prosthetic hand that provides realistic and real-time thermal feedback, Fabrizio, a 57-year-old man from Pistoia with a transradial (wrist) amputation, was able to discriminate between and manually sort objects of different temperatures or materials and ...
2024-02-09
The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity. A new perspective paper in the journal Neuron argues that like many professionals, neuroscientists can either benefit from partnering with these powerful tools or risk being left behind.
In their previous studies, the authors showed that important preconditions are met to develop LLMs that can interpret and analyze neuroscientific data like ChatGPT interprets language. These AI models can be built for many different types ...
2024-02-09
About The Study: This study including 202,000 veterans with COVID-19 and 202,000 matched uninfected veterans found that outpatient use increased significantly in the month after infection, then attenuated but remained greater than the uninfected cohorts’ use through 12 months, which suggests that there are sustained impacts of COVID-19 infection.
Authors: Matthew L. Maciejewski, Ph.D., of the Durham Veterans Affairs Health Care System in Durham, North Carolina, is the corresponding author.
To access the embargoed study: Visit our For The Media ...
2024-02-09
About The Study: The findings of this study including 133 adults with severe obesity suggest that bariatric surgery was associated with health benefits two years after surgery. Bariatric surgery was associated with improved cognition and general health and changed blood vessel efficiency and cortical thickness of the temporal cortex. These results may improve treatment options for patients with obesity and dementia.
Authors: Amanda J. Kiliaan, Ph.D., of the Radboud University Medical Center, Donders Institute for Brain, Cognition, ...
2024-02-09
A technique can determine for the first time how frequently, and exactly where, a molecular event called “backtracking” occurs throughout the genetic material (genome) of any species, a new study shows.
Published online February 9 in Molecular Cell, the study results support the theory that backtracking represents a widespread form of gene regulation, which influences thousands of human genes, including many involved in basic life processes like cell division and development in the womb.
Led by researchers from NYU Grossman School of Medicine, the work revolves around genes, the stretches ...
2024-02-09
BOSTON, MA — A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one step toward improving health outcomes.
The study, “Acute Diabetes Complications After Transition to a Value-Based Medication Benefit,” was published in the February 9 edition of JAMA Health Forum.
Treatment with antidiabetic agents, antihypertensives, and lipid-lowering ...
2024-02-09
An international research project led by the Martin Luther University Halle-Wittenberg (MLU) delves into the next generation of seasonal thermal energy storage systems. The "INTERSTORES" project is investigating optimal ways to construct new types of storage systems and integrate them into energy systems. The collaboration between science and industry will receive nearly eleven million euros as part of "Horizon Europe", with around 1.5 million euros going to MLU. The aim is to improve the ...
2024-02-09
L'Hospitalet de Llobregat, February 8th, 2024. Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion. This biotransformation results in a gradual disappearance of the drug, which is converted into its metabolites. These, in turn, can reach high concentrations in the body and also show a biological activity that may be different from that of the original drug. That is, the metabolites and the drug coexist ...
LAST 30 PRESS RELEASES:
[Press-News.org] Data shows significant prevalence of sleep apnea among cardio-oncology patients
According to researchers, sleep apnea could be used as a risk factor for patients at higher risk for developing congestive heart failure following cancer treatment
